glp-1 and brain health Could diabetes weight loss drugs treat Alzheimer's disease? GLP-1 Medications: A Game Changer

It may feel like you have a cloud (or fog) over your brain

HOBIT tackles that constraint by producing oxygen directly within the implant

Results In vitro testing of GSH production modulation We explored how nutrients can modulate and support GSH production in rat astrocytes

There should be no synthetic fillers, artificial flavors, or unnecessary binders

Petrelintide (ZP8396) Petrelintide (ZP8396) is a novel SC-administered, long-acting amylin analog, developed by Zealand Pharma (Sborg, Denmark), a peptide drug discovery and development company, which is currently in early-stage clinical trials (phase 1 clinical trials: ClinicalTrials.gov Identifier NCT05511025, NCT05096598 and NCT05613387) [116]

PubMed Stephens NG, Parsons A, Schofield PM, et al